Global Polymeric Biomaterials Market Poised To Grow At A Robust Pace Due To Increasing Usage In Various Medical Applications
![]() |
Polymeric Biomaterials Market |
Market Overview
Polymeric biomaterials are materials used in medical devices and implants that
are intended to interact with biological systems. Some common polymeric
biomaterials include collagen, starch, cellulose, silk, chitosan, alginate,
PHB, PLA, PLGA and PCL. These biomaterials find widespread applications in
tissue engineering, orthopedics, cardiology, neurology and dentistry due to
their biodegradability, biocompatibility and bioactivity. Rising prevalence of
chronic diseases and the growing global geriatric population has propelled the
demand for innovative medical devices and implants. Polymeric biomaterials
provide several advantages in implantable devices and tissue engineering
products over conventional metals and ceramics such as flexibility, heat
resistance and tailorable mechanical properties. Moreover, advances in polymer
synthesis techniques and nanotechnology have enabled manufacturers to design
advanced biomaterials with greater functionalities and improved patient
outcomes. The Global polymeric biomaterials market is estimated to be valued at
US$ 48.85 BN in 2024 and is expected to exhibit a CAGR of 16.% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global polymeric biomaterials market are
Stryker, BASF SE, Evonik Industries AG, DSM, Bezwada Biomedical, LLC, Corbion,
Victrex plc (Invibio Ltd.), International Polymer Engineering, Covalon
Technologies Ltd., Medtronic, Abbott, Elixir Medical, REVA Medical, LLC, Meril
Life Sciences Pvt. Ltd., and MicroPort Scientific Corporation. These players
are focusing on extensive R&D efforts to develop novel polymeric
biomaterials tailored for specific clinical applications. For instance, Stryker
has developed various advanced polymeric formulations for orthopedic
applications.
There is a growing demand for bioabsorbable and biodegradable polymeric
biomaterials for short-term implant applications such as sutures and fixation
devices in trauma and sports medicine procedures. Additionally, development of
strong & flexible biomaterials for long-term implants such as joint
replacements, stents and breast implants present major commercial opportunities
in this market.
Key players are expanding their geographical presence
through partnerships and acquisitions to leverage opportunities in emerging
markets. For example, DSM acquired Royal DSM’s Resorbable Polymers Business
Unit in 2021 to expand its portfolio of biomaterials for medical device
applications. Meanwhile, Evonik and Covalon have partnered to develop a product
pipeline containing antimicrobial polymeric biomaterials to address the
emerging threat of healthcare associated infections.
Market Drivers
Growing prevalence of chronic diseases such as cardiovascular diseases and
rising geriatric population are major demand drivers for various advanced
medical devices and implants. For example, cardiovascular diseases account for
over 17 million deaths annually globally. Polymeric biomaterials have become
materials of choice for devices and implants used in interventional cardiology
procedures including stents and grafts.
Increasing fund allocations for research in tissue engineering and regenerative
medicine is also encouraging development of innovative biomaterial-based
solutions by private and public funding bodies globally. Moreover, advancements
in nanotechnology and 3D printing have enabled design of advanced biomaterials
with improved biocompatibility and biomechanical properties for tissue
regeneration and drug delivery applications.
Market Restraints
High raw material costs associated with development of specialized
biomedical grade polymers pose a major challenge. Moreover, lengthy product
approval and regulatory compliance processes further increase the costs and
timelines for market entry. Lack of standardized product testing methods also
acts as a roadblock. Additionally, concerns regarding device failures requiring
revision surgeries and risks of long-term immunological responses to implanted
biomaterials also restrain complete adoption.
Segment
Analysis
The global
polymeric biomaterials market analysis is dominated by medical devices
sub-segment owing to the increasing usage of polymeric biomaterials for
manufacturing various medical devices including implants, sutures, scaffolds,
prosthetics, and others. Polymeric biomaterials offer desirable properties such
as biocompatibility, hydrophilicity, and biodegradability which make them
suitable for manufacturing medical devices. They prevent post-surgical
complications and enhance patient outcomes.
Global Analysis
North America dominates the global polymeric biomaterials market and is
expected to continue its dominance during the forecast period. The large market
share of North America is attributed to the presence of major players, developed
healthcare infrastructure, rising research and development activities, and high
adoption of advanced biomaterials for medical applications in the region.
However, Asia Pacific is projected to witness the highest growth over the next
few years owing to increasing healthcare expenditure, rising geriatric
population, growing demand for medical implants and devices, and expanding
pharmaceutical and biotechnology industry in developing countries such as India
and China.
Get more insights on
this topic: https://www.ukwebwire.com/global-polymeric-biomaterials-market-industry-insightstrendsglobal-polymeric-biomaterials-market/
Explore
more information on this topic, Please visit: https://captionssky.com/bridging-nature-and-innovation-unravelling-the-wonders-of-synthetic-biologys-genetic-tapestry/
Comments
Post a Comment